Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Mech Dev ; 154: 203-207, 2018 12.
Article in English | MEDLINE | ID: mdl-30031069

ABSTRACT

The transcription factor Hif-1α regulates epithelial to mesenchymal transition and neural crest cell chemotaxis in Xenopus. Hif-1α is only stabilised under low oxygen levels, and the in vivo stabilisation of this factor in neural crest cells is poorly understood. Multiple oxygen-independent Hif-1α regulators have been described in cell cultures and cancer models. Among these, the PDGF pathway has been linked to neural crest development. The present study established a connection between the Pdgf pathway and Hif-1α stabilisation in zebrafish. Specifically, embryos with a disrupted Pdgf pathway were rescued by employing hif-1α mRNA through qPCR and immunohistochemistry techniques. The data suggest that oxygen levels in the neural crest are normal and that Pdgf1aa regulates neural crest migration through Hif-1α expression.


Subject(s)
Cell Movement/genetics , Hypoxia-Inducible Factor 1, alpha Subunit/genetics , Neural Crest/growth & development , Oxygen/metabolism , Zebrafish Proteins/genetics , Zebrafish/genetics , Animals , Epithelial-Mesenchymal Transition/genetics , Organogenesis/genetics , Xenopus laevis/genetics
2.
Oncogene ; 25(57): 7545-53, 2006 Dec 04.
Article in English | MEDLINE | ID: mdl-17143299

ABSTRACT

In order to function properly, the brain must be wired correctly during critical periods in early development. Mistakes in this process are hypothesized to occur in disorders like autism and schizophrenia. Later in life, signaling pathways are essential in maintaining proper communication between neuronal and non-neuronal cells, and disrupting this balance may result in disorders like Alzheimer's disease. The Wnt/beta-catenin pathway has a well-established role in cancer. Here, we review recent evidence showing the involvement of Wnt/beta-catenin signaling in neurodevelopment as well as in neurodegenerative diseases. We suggest that the onset/development of such pathological conditions may involve the additive effect of genetic variation within Wnt signaling components and of molecules that modulate the activity of this signaling cascade.


Subject(s)
Gene Expression Regulation , Nervous System Diseases/metabolism , Wnt Proteins/physiology , Alzheimer Disease/metabolism , Animals , Apolipoproteins E/metabolism , Autistic Disorder , Genetic Variation , Humans , Neurodegenerative Diseases/metabolism , Polymorphism, Genetic , Schizophrenia/genetics , Schizophrenia/metabolism , Signal Transduction , Wnt Proteins/metabolism
3.
Mol Psychiatry ; 8(2): 195-208, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12610652

ABSTRACT

Alzheimer's disease (AD) is a progressive neurodegenerative disorder, which is probably caused by the cytotoxic effect of the amyloid beta-peptide (Abeta). We report here molecular changes induced by Abeta, both in neuronal cells in culture and in rats injected in the dorsal hippocampus with preformed Abeta fibrils, as an in vivo model of the disease. Results indicate that in both systems, Abeta neurotoxicity resulted in the destabilization of endogenous levels of beta-catenin, a key transducer of the Wnt signaling pathway. Lithium chloride, which mimics Wnt signaling by inhibiting glycogen synthase kinase-3beta promoted the survival of post-mitotic neurons against Abeta neurotoxicity and recovered cytosolic beta-catenin to control levels. Moreover, the neurotoxic effect of Abeta fibrils was also modulated with protein kinase C agonists/inhibitors and reversed with conditioned medium containing the Wnt-3a ligand. We also examined the spatial memory performance of rats injected with preformed Abeta fibrils in the Morris water maze paradigm, and found that chronic lithium treatment protected neurodegeneration by rescuing beta-catenin levels and improved the deficit in spatial learning induced by Abeta. Our results are consistent with the idea that Abeta-dependent neurotoxicity induces a loss of function of Wnt signaling components and indicate that lithium or compounds that mimic this signaling cascade may be putative candidates for therapeutic intervention in Alzheimer's patients.


Subject(s)
Alzheimer Disease/metabolism , Nerve Degeneration/metabolism , Proteins/metabolism , Signal Transduction/physiology , Alzheimer Disease/drug therapy , Alzheimer Disease/pathology , Amyloid beta-Peptides/metabolism , Animals , Behavior, Animal/drug effects , Cell Death/drug effects , Cell Death/physiology , Cells, Cultured , Culture Media, Conditioned/pharmacology , Cytoskeletal Proteins/metabolism , Humans , Isoenzymes/metabolism , Kidney/cytology , Lithium/pharmacology , Memory Disorders/metabolism , Memory Disorders/pathology , Mice , Nerve Degeneration/drug therapy , Nerve Degeneration/pathology , Neurons/drug effects , Neurons/metabolism , Neurons/pathology , Protein Kinase C/metabolism , Proteins/genetics , Rats , Rats, Sprague-Dawley , Trans-Activators/metabolism , Transfection , Wnt Proteins , Wnt3 Protein , Wnt3A Protein , beta Catenin
4.
Biochemistry ; 40(35): 10447-57, 2001 Sep 04.
Article in English | MEDLINE | ID: mdl-11523986

ABSTRACT

Acetylcholinesterase (AChE) has been found to be associated with the core of senile plaques. We have shown that AChE interacts with the amyloid beta-peptide (Abeta) and promotes amyloid fibril formation by a hydrophobic environment close to the peripheral anionic binding site (PAS) of the enzyme. Here we present evidence for the structural motif of AChE involved in this interaction. First, we modeled the docking of Abeta onto the structure of Torpedo californica AChE, and identified four potential sites for AChE-Abeta complex formation. One of these, Site I, spans a major hydrophobic sequence exposed on the surface of AChE, which had been previously shown to interact with liposomes [Shin et al. (1996) Protein Sci. 5, 42-51]. Second, we examined several AChE-derived peptides and found that a synthetic 35-residue peptide corresponding to the above hydrophobic sequence was able to promote amyloid formation. We also studied the ability to promote amyloid formation of two synthetic 24-residue peptides derived from the sequence of a Omega-loop, which has been suggested as an AChE-Abeta interacting motif. Kinetic analyses indicate that only the 35-residue hydrophobic peptide mimics the effect of intact AChE on amyloid formation. Moreover, RP-HPLC analysis revealed that the 35-residue peptide was incorporated into the growing Abeta-fibrils. Finally, fluorescence binding studies showed that this peptide binds Abeta with a K(d) = 184 microM, independent of salt concentration, indicating that the interaction is primarily hydrophobic. Our results indicate that the homologous human AChE motif is capable of accelerating Abeta fibrillogenesis.


Subject(s)
Acetylcholinesterase/chemistry , Amyloid beta-Peptides/chemistry , Plaque, Amyloid/chemistry , Acetylcholinesterase/isolation & purification , Amino Acid Sequence , Animals , Brain Chemistry , Cattle , Humans , Models, Molecular , Molecular Sequence Data , Plaque, Amyloid/ultrastructure , Protein Conformation , Solubility , Torpedo
5.
J Biol Chem ; 276(26): 23282-7, 2001 Jun 29.
Article in English | MEDLINE | ID: mdl-11313335

ABSTRACT

Three-dimensional structures of acetylcholinesterase (AChE) reveal a narrow and deep active site gorge with two sites of ligand binding, an acylation site at the base of the gorge, and a peripheral site near the gorge entrance. Recent studies have shown that the peripheral site contributes to catalytic efficiency by transiently binding substrates on their way to the acylation site, but the question of whether the peripheral site makes other contributions to the catalytic process remains open. A possible role for ligand binding to the peripheral site that has long been considered is the initiation of a conformational change that is transmitted allosterically to the acylation site to alter catalysis. However, evidence for conformational interactions between these sites has been difficult to obtain. Here we report that thioflavin T, a fluorophore widely used to detect amyloid structure in proteins, binds selectively to the AChE peripheral site with an equilibrium dissociation constant of 1.0 microm. The fluorescence of the bound thioflavin T is increased more than 1000-fold over that of unbound thioflavin T, the greatest enhancement of fluorescence for the binding of a fluorophore to AChE yet observed. Furthermore, when the acylation site ligands edrophonium or m-(N, N,N-trimethylammonio)trifluoroacetophenone form ternary complexes with AChE and thioflavin T, the fluorescence is quenched by factors of 2.7-4.2. The observation of this partial quenching of thioflavin T fluorescence is a major advance in the study of AChE for two reasons. First, it allows thioflavin T to be used as a reporter for ligand reactions at the acylation site. Second, it indicates that ligand binding to the acylation site initiates a change in the local AChE conformation at the peripheral site that quenches the fluorescence of bound thioflavin T. The data provide strong evidence in support of a conformational interaction between the two AChE sites.


Subject(s)
Acetylcholinesterase/metabolism , Fluorescent Dyes/chemistry , Thiazoles/chemistry , Acetophenones/metabolism , Acylation , Benzothiazoles , Binding Sites , Cholinesterase Inhibitors/metabolism , Coloring Agents/chemistry , Dose-Response Relationship, Drug , Edrophonium/metabolism , Fluorescent Dyes/metabolism , Fluorescent Dyes/pharmacology , Humans , Propidium/chemistry , Protein Conformation , Thiazoles/metabolism , Thiazoles/pharmacology
6.
Brain Res Brain Res Rev ; 33(1): 1-12, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10967351

ABSTRACT

Alzheimer's disease (AD) is a neurodegenerative disease with progressive dementia accompanied by three main structural changes in the brain: diffuse loss of neurons; intracellular protein deposits termed neurofibrillary tangles (NFT) and extracellular protein deposits termed amyloid or senile plaques, surrounded by dystrophic neurites. Two major hypotheses have been proposed in order to explain the molecular hallmarks of the disease: The 'amyloid cascade' hypothesis and the 'neuronal cytoskeletal degeneration' hypothesis. While the former is supported by genetic studies of the early-onset familial forms of AD (FAD), the latter revolves around the observation in vivo that cytoskeletal changes - including the abnormal phosphorylation state of the microtubule associated protein tau - may precede the deposition of senile plaques. Recent studies have suggested that the trafficking process of membrane associated proteins is modulated by the FAD-linked presenilin (PS) proteins, and that amyloid beta-peptide deposition may be initiated intracellularly, through the secretory pathway. Current hypotheses concerning presenilin function are based upon its cellular localization and its putative interaction as macromolecular complexes with the cell-adhesion/signaling beta-catenin molecule and the glycogen synthase kinase 3beta (GSK-3beta) enzyme. Developmental studies have shown that PS proteins function as components in the Notch signal transduction cascade and that beta-catenin and GSK-3beta are transducers of the Wnt signaling pathway. Both pathways are thought to have an important role in brain development, and they have been connected through Dishevelled (Dvl) protein, a known transducer of the Wnt pathway. In addition to a review of the current state of research on the subject, we present a cell signaling model in which a sustained loss of function of Wnt signaling components would trigger a series of misrecognition events, determining the onset and development of AD.


Subject(s)
Alzheimer Disease/metabolism , Alzheimer Disease/physiopathology , Proto-Oncogene Proteins/metabolism , Signal Transduction/physiology , Zebrafish Proteins , Alzheimer Disease/pathology , Animals , Humans , Wnt Proteins
7.
Acta Neurol Scand Suppl ; 176: 53-9, 2000.
Article in English | MEDLINE | ID: mdl-11261806

ABSTRACT

Previous studies have indicated that acetylcholinesterase (AChE) promotes amyloid-beta-peptide (Abeta) fibril formation and AChE-Abeta complexes increase Abeta-dependent neurotoxicity. Here we present evidence for the: i) identification of the AChE motif that promotes amyloid formation, ii) in vivo effect of AChE on brain plaque formation, and iii) connection between AChE-Abeta neurotoxicity and the Wnt signal transduction pathway. Computer modeling, stereotaxic infusions and cell biological techniques were used to study the above problems. Results indicated that a 3.4 kDa AChE peptide promotes Abeta fibril formation. AChE infusion into rat hippocampus determines the appearance of anti-Abeta and thioflavine-S positive plaques, and AChE-Abeta toxicity on hippocampal cultures was blocked by lithium, an activator of the Wnt cascade. We suggest that AChE-Abeta/Abeta dependent neurotoxicity may result in loss of function of Wnt signaling components, and open the possibility that lithium may be considered as a candidate for therapeutic intervention in Alzheimer's disease pathology.


Subject(s)
Acetylcholinesterase/metabolism , Alzheimer Disease/physiopathology , Amyloid beta-Peptides/toxicity , Amyloid beta-Protein Precursor/metabolism , Plaque, Amyloid/pathology , Proto-Oncogene Proteins/metabolism , Zebrafish Proteins , Amyloid beta-Peptides/metabolism , Animals , Computer Simulation , Hippocampus/pathology , Male , Neurofibrils/pathology , Proto-Oncogene Proteins/genetics , Rats , Rats, Sprague-Dawley , Signal Transduction , Wnt Proteins
8.
Protein Eng ; 12(11): 959-66, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10585501

ABSTRACT

The main component of the amyloid senile plaques found in Alzheimer's brain is the amyloid-beta-peptide (A beta), a proteolytic product of a membrane precursor protein. Previous structural studies have found different conformations for the A beta peptide depending on the solvent and pH used. In general, they have suggested an alpha-helix conformation at the N-terminal domain and a beta-sheet conformation for the C-terminal domain. The structure of the complete A beta peptide (residues 1-40) solved by NMR has revealed that only helical structure is present in A beta. However, this result cannot explain the large beta-sheet A beta aggregates known to form amyloid under physiological conditions. Therefore, we investigated the structure of A beta by molecular modeling based on extensive homology using the Smith and Waterman algorithm implemented in the MPsrch program (Blitz server). The results showed a mean value of 23% identity with selected sequences. Since these values do not allow a clear homology to be established with a reference structure in order to perform molecular modeling studies, we searched for detailed homology. A 28% identity with an alpha/beta segment of a triosephosphate isomerase (TIM) from Culex tarralis with an unsolved three-dimensional structure was obtained. Then, multiple sequence alignment was performed considering A beta, TIM from C.tarralis and another five TIM sequences with known three-dimensional structures. We found a TIM segment with secondary structure elements in agreement with previous experimental data for A beta. Moreover, when a synthetic peptide from this TIM segment was studied in vitro, it was able to aggregate and to form amyloid fibrils, as established by Congo red binding and electron microscopy. The A beta model obtained was optimized by molecular dynamics considering ionizable side chains in order to simulate A beta in a neutral pH environment. We report here the structural implications of this study.


Subject(s)
Amyloid beta-Peptides/chemistry , Triose-Phosphate Isomerase/chemistry , Algorithms , Alzheimer Disease/metabolism , Amino Acid Sequence , Amyloid beta-Peptides/ultrastructure , Animals , Culex , Escherichia coli , Humans , Microscopy, Electron , Models, Molecular , Molecular Sequence Data , Peptide Fragments/chemistry , Peptide Fragments/ultrastructure , Protein Structure, Secondary , Sequence Alignment , Sequence Homology, Amino Acid , Software
9.
J Neurosci Res ; 52(4): 435-44, 1998 May 15.
Article in English | MEDLINE | ID: mdl-9589388

ABSTRACT

Alzheimer's disease (AD) is associated with a reduction in cholinergic activity as a result of specific neuronal loss. Current potential treatments for the disease include both cholinomimetic drugs and anticholinesterase inhibitors. One of the drugs approved by the FDA is tacrine (9-amine-1,2,3,4 tetrahydroacridine; THA), a strong acetylcholinesterase (AChE) inhibitor. We have studied the effects of tacrine on glial and neuronal cells in culture assessing cell survival and viability and morphology. Lactate dehydrogenase (LDH) activity and methylthiazol-diphenyl-tetrazolium (MTT) reduction were used as toxicity indicators. We found that tacrine toxicity on rat B12 glial cells and mouse Neuro 2A cells was strongly dependent on its concentration (up to 500 microM) and time of exposure. The toxic effect was not prevented by serum factors nor by bovine serum albumin. Fluorescein-conjugated phalloidin was used to examine the arrangement of actin filaments at substrate adhesion regions and cell-cell contacts. Primary events following exposure to tacrine included changes in cell morphology, disappearance of actin filament bundles, and disruption of focal adhesion contacts. At concentrations between 10 and 50 microM, tacrine induced neurite outgrowth in Neuro 2A cells, an effect that was not observed in B12 cells, suggesting that certain tacrine effects could be specific for neuronal cells. Although similar trends of response were observed for both cell types, some differences between undifferentiated and differentiated cells were apparent.


Subject(s)
Neurons/drug effects , Tacrine/toxicity , Animals , Cell Differentiation/drug effects , Cell Size/drug effects , Dose-Response Relationship, Drug , Glioma , Mice , Neuroblastoma , Neuroglia/drug effects , Neurons/pathology , Rats , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...